The Evergreen Editorial Team

Editorial team at Evergreen Telehealth.

Content

The Role of Glycine in Metabolic Health

The Role of Glycine in Metabolic Health

Glycine isn't just an amino acid building block, it may support insulin sensitivity, antioxidant defense, and muscle preservation. Here's the research.

A Note From Evergreen on the July 2026 PCAC Peptide Review

A Note From Evergreen on the July 2026 PCAC Peptide Review

Our statement on the FDA Pharmacy Compounding Advisory Committee's July 23–24, 2026 review of seven peptides, six recommended, one rejected. None are legal to compound today.

DSIP (Emideltide) Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

DSIP (Emideltide) Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

PCAC voted against recommending DSIP (Emideltide) for the FDA Section 503A Bulks List. Compounding is not authorized, here's where things stand.

Semax Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

Semax Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

PCAC voted to recommend Semax for the FDA Section 503A Bulks List. Compounding is not yet legal, here's exactly where things stand.

KPV Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

KPV Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

PCAC voted to recommend KPV for the FDA Section 503A Bulks List. Compounding is not yet legal, here's exactly where things stand.

TB-500 Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

TB-500 Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

PCAC voted to recommend TB-500 for the FDA Section 503A Bulks List. Compounding is not yet legal, here's exactly where things stand.

BPC-157 Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

BPC-157 Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

PCAC voted 8-6 to recommend BPC-157 for the FDA Section 503A Bulks List. Compounding is not yet legal, here's exactly where things stand.

MOTS-c Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

MOTS-c Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

PCAC voted to recommend MOTS-c for the FDA Section 503A Bulks List. Compounding is not yet legal, here's exactly where things stand.

Epitalon Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

Epitalon Regulatory Status: What the July 2026 FDA Advisory Committee Vote Means

PCAC voted to recommend Epitalon for the FDA Section 503A Bulks List. Compounding is not yet legal, here's exactly where things stand.

Woman stretching her arms as she sits on the edge of a bed in a bright bedroom

GLP-1 Weight Loss: The Complete Guide

Evergreen Editorial Team

Smiling man in an orange shirt sitting on a couch in front of bookshelves

GLP-1 Weight Loss Treatment: How It Works

Evergreen Editorial Team

Smiling woman in a denim jacket and glasses working on a laptop at a cafe table

Semaglutide vs. Tirzepatide: Full Comparison

Evergreen Editorial Team

Woman in a pink jacket pausing on outdoor city steps with her hand on the railing

How Long Until My GLP-1 Starts Working?

Evergreen Editorial Team

Woman at a kitchen table covering her mouth with her hand in front of a plate of salad

Why GLP-1 Medications Cause Nausea (and Fixes)

Evergreen Editorial Team

Close-up of a woman sitting on a sofa holding her stomach with both hands

What Are the Possible Side Effects of GLP-1s?

Evergreen Editorial Team

Man in a red shirt curling a dumbbell while seated in a gym

Protect Muscle During GLP-1 Weight Loss

Evergreen Editorial Team

Woman doing a lunge with dumbbells on a green exercise mat outdoors

What Is Metabolic Health?

Evergreen Editorial Team

Woman in a light blue shirt resting her chin on her hand while sitting on a sofa at home

What Should I Expect From a GLP-1 Prescription?

Evergreen Editorial Team

Gloved lab scientist adding liquid by pipette to a rack of test tubes filled with blue solution

Why All Peptides Are Not Created Equal

Evergreen Editorial Team